Search results for "Bovine lactoferrin"

showing 3 items of 3 documents

Antihypertensive effect of a bovine lactoferrin pepsin hydrolysate: Identification of novel active peptides

2012

et al.

ChromatographybiologyMolecular massChemistryLactoferrinGeneral MedicineHydrolysateAnalytical ChemistryBioavailabilityfluids and secretionsPepsinBiochemistryBovine lactoferrinbiology.proteinAce inhibitionFood ScienceFood Chemistry
researchProduct

Antihypertensive Mechanism of Lactoferrin-Derived Peptides: Angiotensin Receptor Blocking Effect

2013

Texto del artículo, no incluye figuras ni tablas.

Malemedicine.medical_specialtyAngiotensin receptorPeptideLactoferrin-derived peptidesReceptor Angiotensin Type 1Angiotensin Receptor AntagonistsInternal medicineRenin–angiotensin systemmedicineAnimalsHumansAngiotensin receptor blockerRenin−angiotensin systemReceptorAntihypertensive Agentschemistry.chemical_classificationAngiotensin II receptor type 1Antihypertensive mechanismbiologyLactoferrinAngiotensin IIBovine lactoferrin hydrolysateGeneral ChemistryAngiotensin IIMolecular WeightLactoferrinEndocrinologychemistryVasoconstrictionAngiotensin-converting enzyme inhibitorHypertensionbiology.proteinRabbitsPeptidesGeneral Agricultural and Biological SciencesEx vivo
researchProduct

Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial.

2011

Background: Lactoferrin is a mammalian milk glycoprotein involved in innate immunity. Recent data show that bovine lactoferrin (bLF) prevents late-onset sepsis in preterm very low birth weight (VLBW) neonates. Methods: This is a secondary analysis of data from a multicenter randomized controlled trial where preterm VLBW neonates randomly received bLF (100 mg/day; group A1), bLF + Lactobacillus rhamnosus GG (106 colony-forming units per day; group A2), or placebo (group B) for 6 weeks. Here we analyze the incidence rates of fungal colonization, invasive fungal infection (IFI), and rate of progression from colonization to infection in all groups. Results: This study included 472 neonates who…

fungal sepsisDiseasesInfant Premature DiseasesPediatricsGastroenterologylactoferrin; VLBW neonates; Candida; fungal sepsis; prophylaxisGroup BSettore MED/38 - Pediatria Generale E SpecialisticaAnti-Infective AgentsInfant Very Low Birth WeightCandidabiologyLactoferrinBovine lactoferrin fungal infections very low birth weight newbornsPerinatology and Child Healthlactoferrinprophylaxismedicine.symptomInfant Prematuremedicine.medical_specialtyFungal sepsisPlaceboSepsisLactobacillus rhamnosusIntolerancesInternal medicinemedicineAnimalsHumansfungal sepsiAdverse effectPrematureProphylaxisbusiness.industryVery Low Birth WeightProbioticsInfant NewbornInfantNewbornbiology.organism_classificationmedicine.diseaseLactoferrinLow birth weightMycosesVLBW neonatesPediatrics Perinatology and Child HealthImmunologyCandida; Fungal sepsis; Lactoferrin; Prophylaxis; VLBW neonates; Animals; Anti-Infective Agents; Cattle; Humans; Infant Newborn; Infant Premature; Infant Premature Diseases; Lactoferrin; Mycoses; Probiotics; Infant Very Low Birth Weight; Pediatrics Perinatology and Child Healthbiology.proteinCattlebusiness
researchProduct